One thing I always keep an eye on when researching stocks to buy is director dealing. Corporate directors have far more information on their businesses than the rest of us. If theyâre buying company stock, itâs often worth taking a closer look.
Here, Iâm going to highlight some interesting director dealing Iâve spotted recently. Should I follow these insiders into these stocks?
ÂŁ99k buy from the CFO
Letâs start with asset manager abrdn (LSE: ABDN). Here, CFO Stephanie Bruce bought 66,709 shares at an average price of 148p on 5 September. This purchase cost the insider around ÂŁ99,000.
I think itâs significant that abrdnâs CFO has bought stock. Finance chiefs are top-level insiders and they generally have an excellent understanding of their companiesâ operating activities and financials. I also think itâs interesting that Bruce has invested nearly ÂŁ100k in stock. This suggests sheâs quite confident Abrdnâs share price is set to rise.
However, itâs worth pointing out that she also made large purchases in March and December when the stock was trading at much higher levels. So her track record, in terms of timing, isnât great.
Would I buy abrdn shares today? The answer to that is no. The stock does offer a high yield. However, I have a few concerns in relation to the company’s competitive advantage.
Itâs worth noting that analysts at Deutsche Bank just downgraded the stock from âholdâ to âsellâ.
Purchases from the CEO and CFO
Next up is housebuilder Vistry (LSE: VTY). Here, both CEO Greg Fitzgerald and CFO Earl Sibley bought stock on 8 September when it was trading at 804p. Combined, the two insiders spent around ÂŁ248,000 on stock.
So now we have two top-level directors buying stock. Thatâs notable, to my mind. The more insiders buying, the more powerful the trading signal.
Vistry shares do look cheap at present. Currently, they trade at just five times this yearâs earnings forecast. So there could be some value on offer here right now.
Having said that, I see this stock as quite risky, given current economic conditions. In recessions, housebuilders tend to underperform.
Given the risks, I think the safest move for me is to leave this stock alone for now.
ÂŁ102k buy from a clued-up director
Finally, AIM-listed Alpha FX (LSE: AFX). It saw a ÂŁ102,000 buy from board member Lisa Gordon on 13 September.
This director dealing activity looks really interesting to me due to the fact that Gordon has an investment background. Earlier in her career, she worked as an equity analyst. Meanwhile, she is also Chair of stockbroker Cenkos Securities. So we can assume she knows what sheâs doing here.
Alpha FX continues to grow at a strong rate. Recently, the group posted revenue growth of 35% for the first half of 2022. And founder and CEO Morgan Tillbrook was very optimistic about the future.
âAlthough much of the world is moving into a challenging macro environment, I have never felt more confident about the potential of the business and our long-term growth prospects,â he said.
Putting this all together, Iâd buy Alpha FX shares for my portfolio today. The stock isnât cheap, so there is some valuation risk. However, all things considered, I see the risk/reward proposition here as attractive.